Innovation
5 patent families — focus: Human necessities; filing pace slowing. Cited 84 times.
| Year | Filings |
|---|---|
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 4 |
Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |
An integrated Biopharma company with products in Immunotherapy and Tissue Engineering
5 patent families — focus: Human necessities; filing pace slowing. Cited 84 times.
| Year | Filings |
|---|---|
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 4 |
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 2 | 100% |